Market Research Logo

Vietnam Pharmaceuticals and Healthcare Report Q1 2015


Attention: There is an updated edition available for this report.

Vietnam Pharmaceuticals and Healthcare Report Q1 2015

BMI View: With a growing and ageing population, Vietnam plays host to an attractive target forpharmaceutical and healthcare growth. While per capita spending remains low, and current healthcareinfrastructure appears strained, access to healthcare coverage is steadily increasing.

Headline Expenditure Projections

Pharmaceuticals: VND69,297bn (USD3.30bn) in 2013 to VND80,730bn (USD3.80bn) in 2014; +17.0%in local currency terms and +16.2% in US dollar terms. Forecast unchanged from previous quarter.

Healthcare: VND222,374bn (USD10.57bn) in 2013 to VND254,679bn (USD11.99bn) in 2014; +14.7%in local currency terms and +13.9% in US dollar terms. Forecast unchanged from previous quarter.


BMI Industry View
SWOT
Political
Economic
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Vietnam 2010-2018)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Vietnam 2010-2018)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Vietnam 2010-2018)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Vietnam 2010-2018)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Vietnam 2010-2018)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Vietnam 2010-2018)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Vietnam 2010-2018)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Vietnam 2010-2018)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Vietnam 2012-2018)
Table: Pharmaceutical Trade Data And Forecasts local currency (Vietnam 2012-2018)
Other Healthcare Data
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Expecting Sustained Growth Momentum In 2015
Table: Economic Activity (Vietnam 2009-2018)
Industry Risk Reward Index
Asia Pacific Risk/Reward Index
Vietnam Risk Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Healthcare Financing
Hospital Sector
Private Healthcare Sector
Healthcare Insurance
Healthcare And Pharmaceutical Reform
Research And Development
Biotechnology Sector
Clinical Trials
Regulatory Development
Regulatory Regime
Pharmaceutical Advertising
Intellectual Property Environment
Corruption
Pricing Regime
Reimbursement Regime
Pricing And Reimbursement Developments
Competitive Landscape
Pharmaceutical Sector
Domestic Industry
Foreign Industry
Traditional Medicines
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Table: Key Aspects Of Good Pharmacy Practice In Developing Countries
Company Profile
DHG Pharmaceutical
GlaxoSmithKline
Merck & Co
Novartis
Pfizer
Sanofi
Traphaco Pharmaceutical
Vidipha Central Pharmaceutical Joint Stock Company
Vietnam OPV Pharmaceutical Co
Vietnam Pharmaceutical Corporation (Vinapharm)
Vietnam Pharmaceutical Joint Stock Company (Ampharco)
Demographic Forecast
Table: Population Headline Indicators (Vietnam 1990-2025)
Table: Key Population Ratios (Vietnam 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Vietnam 1990-2025)
Table: Population By Age Group (Vietnam 1990-2025)
Table: Population By Age Group % (Vietnam 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report